Article info

Serum albumin: a pharmacokinetic marker for optimizing treatment outcome of immune checkpoint blockade

Authors

  • Ming Zheng Institute of Military Cognition and Brain Sciences, Academy of Military Medical Sciences, 27 Taiping Road, Beijing 100850, ChinaBeijing Institute of Basic Medical Sciences, 27 Taiping Road, Beijing 100850, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ming Zheng; mmzheng{at}fmmu.edu.cn; zhengming_china{at}163.com
View Full Text

Citation

Zheng M
Serum albumin: a pharmacokinetic marker for optimizing treatment outcome of immune checkpoint blockade

Publication history

  • Accepted October 31, 2022
  • First published December 20, 2022.
Online issue publication 
December 20, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.